Technical Analysis for CRSP - CRISPR Therapeutics AG

Grade Last Price % Change Price Change
grade A 106.7 -0.95% -1.02
CRSP closed down 0.95 percent on Tuesday, October 20, 2020, on 86 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Oct 26
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CRSP trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Reached Overbought Strength -0.95%
Upper Bollinger Band Walk Strength -0.95%
Multiple of Ten Bearish Other -0.95%
Inside Day Range Contraction -0.95%
Wide Bands Range Expansion -0.95%
Overbought Stochastic Strength -0.95%
Upper Bollinger Band Touch Strength -0.95%
Older End-of-Day Gignals for CRSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 8 hours ago
Down 1% about 9 hours ago
Fell Below Previous Day's Low about 9 hours ago
60 Minute Opening Range Breakdown 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Biology Immune System Genetics Serious Diseases Genetic Engineering Enzymes Genome Editing Cas9 CRISPR

Is CRSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 111.9
52 Week Low 32.3
Average Volume 892,814
200-Day Moving Average 68.70
50-Day Moving Average 90.29
20-Day Moving Average 93.07
10-Day Moving Average 101.93
Average True Range 5.60
ADX 29.01
+DI 37.45
-DI 14.07
Chandelier Exit (Long, 3 ATRs ) 95.11
Chandelier Exit (Short, 3 ATRs ) 96.10
Upper Bollinger Band 112.14
Lower Bollinger Band 74.00
Percent B (%b) 0.86
BandWidth 40.99
MACD Line 5.38
MACD Signal Line 3.52
MACD Histogram 1.8651
Fundamentals Value
Market Cap 7.49 Billion
Num Shares 70.2 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 337.66
Price-to-Sales 20.18
Price-to-Book 7.35
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 113.20
Resistance 3 (R3) 113.19 111.01 112.11
Resistance 2 (R2) 111.01 109.36 111.02 111.75
Resistance 1 (R1) 108.86 108.34 107.77 108.87 111.39
Pivot Point 106.68 106.68 106.14 106.69 106.68
Support 1 (S1) 104.53 105.03 103.44 104.54 102.01
Support 2 (S2) 102.35 104.01 102.36 101.65
Support 3 (S3) 100.20 102.35 101.29
Support 4 (S4) 100.21